Why the study?
Should antithrombotic medications be continued periprocedurally in patients with ischemic cerebrovascular disease?
Population
Patients with ischemic cerebrovascular disease undergoing various procedures.
Comparison
Periprocedural continuation of antithrombotic… vs Discontinuation of antithrombotic medications.
Design
Guideline
Authors
Loading...
Supports continuation of aspirin and warfarin for dental and select procedures; confirms Level A/B evidence while cautioning against bridging.
Should antithrombotic medications be continued periprocedurally in patients with ischemic cerebrovascular disease?
This guideline summary provides evidence-based recommendations for continuing aspirin and warfarin during various procedures in patients with ischemic cerebrovascular disease to balance bleeding and thromboembolic risks.
Armstrong et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: